0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nanopharmaceuticals Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-39A444
Home | Market Reports | Health| Pharmacy
Global Nanopharmaceuticals Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Nanopharmaceuticals Market Research Report 2024

Code: QYRE-Auto-39A444
Report
January 2024
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nanopharmaceuticals Market Size

The global Nanopharmaceuticals market was valued at US$ 30960 million in 2023 and is anticipated to reach US$ 73550 million by 2030, witnessing a CAGR of 13.0% during the forecast period 2024-2030.

Nanopharmaceuticals Market

Nanopharmaceuticals Market

Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their “bulk” counterparts primarily because of size.
There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier.
USA is the largest Nanopharmaceuticals market with about 59% market share. Europe is follower, accounting for about 33% market share.
The key players are Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Roche, Sanofi, Eli Lilly, Astrazeneca, Johnson & Johnson, Celgene, Novavax, Stryker, Gilead Sciences, OSI Pharmaceuticals, Kadmon Pharmaceuticals, Samyang Biopharm, Mitsubishi Pharma, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Cerulean Pharma, Navidea Biopharmaceuticals, Lummy etc. Top 3 companies occupied about 34% market share.
This report aims to provide a comprehensive presentation of the global market for Nanopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanopharmaceuticals.

Report Scope

The Nanopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nanopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Nanopharmaceuticals Market Report

Report Metric Details
Report Name Nanopharmaceuticals Market
Accounted market size in 2023 US$ 30960 million
Forecasted market size in 2030 US$ 73550 million
CAGR 13.0%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Liposomes
  • Polymeric Micelles
  • Solid Lipid Nanoparticles
  • Microemulsion and Nnanoemulsion
  • Nanosuspension
Segment by Application
  • Cancer and Tumor
  • Autoimmune Disorders
  • Inflammation
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Roche, Sanofi, Eli Lilly, Astrazeneca, Johnson & Johnson, Celgene, Novavax, Stryker, Gilead Sciences, OSI Pharmaceuticals, Kadmon Pharmaceuticals, Samyang Biopharm, Mitsubishi Pharma, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Cerulean Pharma, Navidea Biopharmaceuticals, Lummy
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nanopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nanopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Nanopharmaceuticals Market growing?

Ans: The Nanopharmaceuticals Market witnessing a CAGR of 13.0% during the forecast period 2024-2030.

What is the Nanopharmaceuticals Market size in 2030?

Ans: The Nanopharmaceuticals Market size in 2030 will be US$ 73550 million.

What is the Nanopharmaceuticals Market share by region?

Ans: USA is the largest Nanopharmaceuticals market with about 59% market share. Europe is follower, accounting for about 33% market share.

What is the market share of major companies in Nanopharmaceuticals Market?

Ans: Top 3 companies occupied about 34% market share.

Who are the main players in the Nanopharmaceuticals Market report?

Ans: The main players in the Nanopharmaceuticals Market are Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Roche, Sanofi, Eli Lilly, Astrazeneca, Johnson & Johnson, Celgene, Novavax, Stryker, Gilead Sciences, OSI Pharmaceuticals, Kadmon Pharmaceuticals, Samyang Biopharm, Mitsubishi Pharma, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Cerulean Pharma, Navidea Biopharmaceuticals, Lummy

What are the Application segmentation covered in the Nanopharmaceuticals Market report?

Ans: The Applications covered in the Nanopharmaceuticals Market report are Cancer and Tumor, Autoimmune Disorders, Inflammation, Others

What are the Type segmentation covered in the Nanopharmaceuticals Market report?

Ans: The Types covered in the Nanopharmaceuticals Market report are Liposomes, Polymeric Micelles, Solid Lipid Nanoparticles, Microemulsion and Nnanoemulsion, Nanosuspension

1 Nanopharmaceuticals Market Overview
1.1 Product Overview and Scope of Nanopharmaceuticals
1.2 Nanopharmaceuticals Segment by Type
1.2.1 Global Nanopharmaceuticals Market Value Comparison by Type (2024-2030)
1.2.2 Liposomes
1.2.3 Polymeric Micelles
1.2.4 Solid Lipid Nanoparticles
1.2.5 Microemulsion and Nnanoemulsion
1.2.6 Nanosuspension
1.3 Nanopharmaceuticals Segment by Application
1.3.1 Global Nanopharmaceuticals Market Value by Application: (2024-2030)
1.3.2 Cancer and Tumor
1.3.3 Autoimmune Disorders
1.3.4 Inflammation
1.3.5 Others
1.4 Global Nanopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Nanopharmaceuticals Revenue 2019-2030
1.4.2 Global Nanopharmaceuticals Sales 2019-2030
1.4.3 Global Nanopharmaceuticals Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nanopharmaceuticals Market Competition by Manufacturers
2.1 Global Nanopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nanopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nanopharmaceuticals Average Price by Manufacturers (2019-2024)
2.4 Global Nanopharmaceuticals Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nanopharmaceuticals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nanopharmaceuticals, Product Type & Application
2.7 Nanopharmaceuticals Market Competitive Situation and Trends
2.7.1 Nanopharmaceuticals Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nanopharmaceuticals Players Market Share by Revenue
2.7.3 Global Nanopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nanopharmaceuticals Retrospective Market Scenario by Region
3.1 Global Nanopharmaceuticals Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nanopharmaceuticals Global Nanopharmaceuticals Sales by Region: 2019-2030
3.2.1 Global Nanopharmaceuticals Sales by Region: 2019-2024
3.2.2 Global Nanopharmaceuticals Sales by Region: 2025-2030
3.3 Global Nanopharmaceuticals Global Nanopharmaceuticals Revenue by Region: 2019-2030
3.3.1 Global Nanopharmaceuticals Revenue by Region: 2019-2024
3.3.2 Global Nanopharmaceuticals Revenue by Region: 2025-2030
3.4 North America Nanopharmaceuticals Market Facts & Figures by Country
3.4.1 North America Nanopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nanopharmaceuticals Sales by Country (2019-2030)
3.4.3 North America Nanopharmaceuticals Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nanopharmaceuticals Market Facts & Figures by Country
3.5.1 Europe Nanopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nanopharmaceuticals Sales by Country (2019-2030)
3.5.3 Europe Nanopharmaceuticals Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nanopharmaceuticals Market Facts & Figures by Country
3.6.1 Asia Pacific Nanopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nanopharmaceuticals Sales by Country (2019-2030)
3.6.3 Asia Pacific Nanopharmaceuticals Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nanopharmaceuticals Market Facts & Figures by Country
3.7.1 Latin America Nanopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nanopharmaceuticals Sales by Country (2019-2030)
3.7.3 Latin America Nanopharmaceuticals Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nanopharmaceuticals Market Facts & Figures by Country
3.8.1 Middle East and Africa Nanopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nanopharmaceuticals Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nanopharmaceuticals Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Nanopharmaceuticals Sales by Type (2019-2030)
4.1.1 Global Nanopharmaceuticals Sales by Type (2019-2024)
4.1.2 Global Nanopharmaceuticals Sales by Type (2025-2030)
4.1.3 Global Nanopharmaceuticals Sales Market Share by Type (2019-2030)
4.2 Global Nanopharmaceuticals Revenue by Type (2019-2030)
4.2.1 Global Nanopharmaceuticals Revenue by Type (2019-2024)
4.2.2 Global Nanopharmaceuticals Revenue by Type (2025-2030)
4.2.3 Global Nanopharmaceuticals Revenue Market Share by Type (2019-2030)
4.3 Global Nanopharmaceuticals Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nanopharmaceuticals Sales by Application (2019-2030)
5.1.1 Global Nanopharmaceuticals Sales by Application (2019-2024)
5.1.2 Global Nanopharmaceuticals Sales by Application (2025-2030)
5.1.3 Global Nanopharmaceuticals Sales Market Share by Application (2019-2030)
5.2 Global Nanopharmaceuticals Revenue by Application (2019-2030)
5.2.1 Global Nanopharmaceuticals Revenue by Application (2019-2024)
5.2.2 Global Nanopharmaceuticals Revenue by Application (2025-2030)
5.2.3 Global Nanopharmaceuticals Revenue Market Share by Application (2019-2030)
5.3 Global Nanopharmaceuticals Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Nanopharmaceuticals Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Nanopharmaceuticals Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Nanopharmaceuticals Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Abbott
6.4.1 Abbott Corporation Information
6.4.2 Abbott Description and Business Overview
6.4.3 Abbott Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Nanopharmaceuticals Product Portfolio
6.4.5 Abbott Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GlaxoSmithKline Nanopharmaceuticals Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Roche Nanopharmaceuticals Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Nanopharmaceuticals Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Eli Lilly
6.8.1 Eli Lilly Corporation Information
6.8.2 Eli Lilly Description and Business Overview
6.8.3 Eli Lilly Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Eli Lilly Nanopharmaceuticals Product Portfolio
6.8.5 Eli Lilly Recent Developments/Updates
6.9 Astrazeneca
6.9.1 Astrazeneca Corporation Information
6.9.2 Astrazeneca Description and Business Overview
6.9.3 Astrazeneca Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Astrazeneca Nanopharmaceuticals Product Portfolio
6.9.5 Astrazeneca Recent Developments/Updates
6.10 Johnson & Johnson
6.10.1 Johnson & Johnson Corporation Information
6.10.2 Johnson & Johnson Description and Business Overview
6.10.3 Johnson & Johnson Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Johnson & Johnson Nanopharmaceuticals Product Portfolio
6.10.5 Johnson & Johnson Recent Developments/Updates
6.11 Celgene
6.11.1 Celgene Corporation Information
6.11.2 Celgene Nanopharmaceuticals Description and Business Overview
6.11.3 Celgene Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Celgene Nanopharmaceuticals Product Portfolio
6.11.5 Celgene Recent Developments/Updates
6.12 Novavax
6.12.1 Novavax Corporation Information
6.12.2 Novavax Nanopharmaceuticals Description and Business Overview
6.12.3 Novavax Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Novavax Nanopharmaceuticals Product Portfolio
6.12.5 Novavax Recent Developments/Updates
6.13 Stryker
6.13.1 Stryker Corporation Information
6.13.2 Stryker Nanopharmaceuticals Description and Business Overview
6.13.3 Stryker Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Stryker Nanopharmaceuticals Product Portfolio
6.13.5 Stryker Recent Developments/Updates
6.14 Gilead Sciences
6.14.1 Gilead Sciences Corporation Information
6.14.2 Gilead Sciences Nanopharmaceuticals Description and Business Overview
6.14.3 Gilead Sciences Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Gilead Sciences Nanopharmaceuticals Product Portfolio
6.14.5 Gilead Sciences Recent Developments/Updates
6.15 OSI Pharmaceuticals
6.15.1 OSI Pharmaceuticals Corporation Information
6.15.2 OSI Pharmaceuticals Nanopharmaceuticals Description and Business Overview
6.15.3 OSI Pharmaceuticals Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.15.4 OSI Pharmaceuticals Nanopharmaceuticals Product Portfolio
6.15.5 OSI Pharmaceuticals Recent Developments/Updates
6.16 Kadmon Pharmaceuticals
6.16.1 Kadmon Pharmaceuticals Corporation Information
6.16.2 Kadmon Pharmaceuticals Nanopharmaceuticals Description and Business Overview
6.16.3 Kadmon Pharmaceuticals Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Kadmon Pharmaceuticals Nanopharmaceuticals Product Portfolio
6.16.5 Kadmon Pharmaceuticals Recent Developments/Updates
6.17 Samyang Biopharm
6.17.1 Samyang Biopharm Corporation Information
6.17.2 Samyang Biopharm Nanopharmaceuticals Description and Business Overview
6.17.3 Samyang Biopharm Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Samyang Biopharm Nanopharmaceuticals Product Portfolio
6.17.5 Samyang Biopharm Recent Developments/Updates
6.18 Mitsubishi Pharma
6.18.1 Mitsubishi Pharma Corporation Information
6.18.2 Mitsubishi Pharma Nanopharmaceuticals Description and Business Overview
6.18.3 Mitsubishi Pharma Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Mitsubishi Pharma Nanopharmaceuticals Product Portfolio
6.18.5 Mitsubishi Pharma Recent Developments/Updates
6.19 Kaken Pharmaceutical
6.19.1 Kaken Pharmaceutical Corporation Information
6.19.2 Kaken Pharmaceutical Nanopharmaceuticals Description and Business Overview
6.19.3 Kaken Pharmaceutical Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Kaken Pharmaceutical Nanopharmaceuticals Product Portfolio
6.19.5 Kaken Pharmaceutical Recent Developments/Updates
6.20 Selecta Biosciences
6.20.1 Selecta Biosciences Corporation Information
6.20.2 Selecta Biosciences Nanopharmaceuticals Description and Business Overview
6.20.3 Selecta Biosciences Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Selecta Biosciences Nanopharmaceuticals Product Portfolio
6.20.5 Selecta Biosciences Recent Developments/Updates
6.21 Par Pharmaceutical
6.21.1 Par Pharmaceutical Corporation Information
6.21.2 Par Pharmaceutical Nanopharmaceuticals Description and Business Overview
6.21.3 Par Pharmaceutical Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Par Pharmaceutical Nanopharmaceuticals Product Portfolio
6.21.5 Par Pharmaceutical Recent Developments/Updates
6.22 Cerulean Pharma
6.22.1 Cerulean Pharma Corporation Information
6.22.2 Cerulean Pharma Nanopharmaceuticals Description and Business Overview
6.22.3 Cerulean Pharma Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Cerulean Pharma Nanopharmaceuticals Product Portfolio
6.22.5 Cerulean Pharma Recent Developments/Updates
6.23 Navidea Biopharmaceuticals
6.23.1 Navidea Biopharmaceuticals Corporation Information
6.23.2 Navidea Biopharmaceuticals Nanopharmaceuticals Description and Business Overview
6.23.3 Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Navidea Biopharmaceuticals Nanopharmaceuticals Product Portfolio
6.23.5 Navidea Biopharmaceuticals Recent Developments/Updates
6.24 Lummy
6.24.1 Lummy Corporation Information
6.24.2 Lummy Nanopharmaceuticals Description and Business Overview
6.24.3 Lummy Nanopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Lummy Nanopharmaceuticals Product Portfolio
6.24.5 Lummy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nanopharmaceuticals Industry Chain Analysis
7.2 Nanopharmaceuticals Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nanopharmaceuticals Production Mode & Process
7.4 Nanopharmaceuticals Sales and Marketing
7.4.1 Nanopharmaceuticals Sales Channels
7.4.2 Nanopharmaceuticals Distributors
7.5 Nanopharmaceuticals Customers
8 Nanopharmaceuticals Market Dynamics
8.1 Nanopharmaceuticals Industry Trends
8.2 Nanopharmaceuticals Market Drivers
8.3 Nanopharmaceuticals Market Challenges
8.4 Nanopharmaceuticals Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Nanopharmaceuticals Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Nanopharmaceuticals Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Nanopharmaceuticals Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Nanopharmaceuticals Sales (K MT) of Key Manufacturers (2019-2024)
    Table 5. Global Nanopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Nanopharmaceuticals Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Nanopharmaceuticals Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Nanopharmaceuticals Average Price (USD/MT) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Nanopharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Nanopharmaceuticals, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Nanopharmaceuticals, Product Type & Application
    Table 12. Global Key Manufacturers of Nanopharmaceuticals, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Nanopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanopharmaceuticals as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Nanopharmaceuticals Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Nanopharmaceuticals Sales by Region (2019-2024) & (K MT)
    Table 18. Global Nanopharmaceuticals Sales Market Share by Region (2019-2024)
    Table 19. Global Nanopharmaceuticals Sales by Region (2025-2030) & (K MT)
    Table 20. Global Nanopharmaceuticals Sales Market Share by Region (2025-2030)
    Table 21. Global Nanopharmaceuticals Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Nanopharmaceuticals Revenue Market Share by Region (2019-2024)
    Table 23. Global Nanopharmaceuticals Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Nanopharmaceuticals Revenue Market Share by Region (2025-2030)
    Table 25. North America Nanopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Nanopharmaceuticals Sales by Country (2019-2024) & (K MT)
    Table 27. North America Nanopharmaceuticals Sales by Country (2025-2030) & (K MT)
    Table 28. North America Nanopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Nanopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Nanopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Nanopharmaceuticals Sales by Country (2019-2024) & (K MT)
    Table 32. Europe Nanopharmaceuticals Sales by Country (2025-2030) & (K MT)
    Table 33. Europe Nanopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Nanopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Nanopharmaceuticals Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Nanopharmaceuticals Sales by Region (2019-2024) & (K MT)
    Table 37. Asia Pacific Nanopharmaceuticals Sales by Region (2025-2030) & (K MT)
    Table 38. Asia Pacific Nanopharmaceuticals Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Nanopharmaceuticals Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Nanopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Nanopharmaceuticals Sales by Country (2019-2024) & (K MT)
    Table 42. Latin America Nanopharmaceuticals Sales by Country (2025-2030) & (K MT)
    Table 43. Latin America Nanopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Nanopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Nanopharmaceuticals Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Nanopharmaceuticals Sales by Country (2019-2024) & (K MT)
    Table 47. Middle East & Africa Nanopharmaceuticals Sales by Country (2025-2030) & (K MT)
    Table 48. Middle East & Africa Nanopharmaceuticals Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Nanopharmaceuticals Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Nanopharmaceuticals Sales (K MT) by Type (2019-2024)
    Table 51. Global Nanopharmaceuticals Sales (K MT) by Type (2025-2030)
    Table 52. Global Nanopharmaceuticals Sales Market Share by Type (2019-2024)
    Table 53. Global Nanopharmaceuticals Sales Market Share by Type (2025-2030)
    Table 54. Global Nanopharmaceuticals Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Nanopharmaceuticals Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Nanopharmaceuticals Revenue Market Share by Type (2019-2024)
    Table 57. Global Nanopharmaceuticals Revenue Market Share by Type (2025-2030)
    Table 58. Global Nanopharmaceuticals Price (USD/MT) by Type (2019-2024)
    Table 59. Global Nanopharmaceuticals Price (USD/MT) by Type (2025-2030)
    Table 60. Global Nanopharmaceuticals Sales (K MT) by Application (2019-2024)
    Table 61. Global Nanopharmaceuticals Sales (K MT) by Application (2025-2030)
    Table 62. Global Nanopharmaceuticals Sales Market Share by Application (2019-2024)
    Table 63. Global Nanopharmaceuticals Sales Market Share by Application (2025-2030)
    Table 64. Global Nanopharmaceuticals Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Nanopharmaceuticals Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Nanopharmaceuticals Revenue Market Share by Application (2019-2024)
    Table 67. Global Nanopharmaceuticals Revenue Market Share by Application (2025-2030)
    Table 68. Global Nanopharmaceuticals Price (USD/MT) by Application (2019-2024)
    Table 69. Global Nanopharmaceuticals Price (USD/MT) by Application (2025-2030)
    Table 70. Merck Corporation Information
    Table 71. Merck Description and Business Overview
    Table 72. Merck Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 73. Merck Nanopharmaceuticals Product
    Table 74. Merck Recent Developments/Updates
    Table 75. Pfizer Corporation Information
    Table 76. Pfizer Description and Business Overview
    Table 77. Pfizer Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 78. Pfizer Nanopharmaceuticals Product
    Table 79. Pfizer Recent Developments/Updates
    Table 80. Novartis Corporation Information
    Table 81. Novartis Description and Business Overview
    Table 82. Novartis Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 83. Novartis Nanopharmaceuticals Product
    Table 84. Novartis Recent Developments/Updates
    Table 85. Abbott Corporation Information
    Table 86. Abbott Description and Business Overview
    Table 87. Abbott Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 88. Abbott Nanopharmaceuticals Product
    Table 89. Abbott Recent Developments/Updates
    Table 90. GlaxoSmithKline Corporation Information
    Table 91. GlaxoSmithKline Description and Business Overview
    Table 92. GlaxoSmithKline Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 93. GlaxoSmithKline Nanopharmaceuticals Product
    Table 94. GlaxoSmithKline Recent Developments/Updates
    Table 95. Roche Corporation Information
    Table 96. Roche Description and Business Overview
    Table 97. Roche Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 98. Roche Nanopharmaceuticals Product
    Table 99. Roche Recent Developments/Updates
    Table 100. Sanofi Corporation Information
    Table 101. Sanofi Description and Business Overview
    Table 102. Sanofi Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 103. Sanofi Nanopharmaceuticals Product
    Table 104. Sanofi Recent Developments/Updates
    Table 105. Eli Lilly Corporation Information
    Table 106. Eli Lilly Description and Business Overview
    Table 107. Eli Lilly Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 108. Eli Lilly Nanopharmaceuticals Product
    Table 109. Eli Lilly Recent Developments/Updates
    Table 110. Astrazeneca Corporation Information
    Table 111. Astrazeneca Description and Business Overview
    Table 112. Astrazeneca Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 113. Astrazeneca Nanopharmaceuticals Product
    Table 114. Astrazeneca Recent Developments/Updates
    Table 115. Johnson & Johnson Corporation Information
    Table 116. Johnson & Johnson Description and Business Overview
    Table 117. Johnson & Johnson Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 118. Johnson & Johnson Nanopharmaceuticals Product
    Table 119. Johnson & Johnson Recent Developments/Updates
    Table 120. Celgene Corporation Information
    Table 121. Celgene Description and Business Overview
    Table 122. Celgene Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 123. Celgene Nanopharmaceuticals Product
    Table 124. Celgene Recent Developments/Updates
    Table 125. Novavax Corporation Information
    Table 126. Novavax Description and Business Overview
    Table 127. Novavax Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 128. Novavax Nanopharmaceuticals Product
    Table 129. Novavax Recent Developments/Updates
    Table 130. Stryker Corporation Information
    Table 131. Stryker Description and Business Overview
    Table 132. Stryker Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 133. Stryker Nanopharmaceuticals Product
    Table 134. Stryker Recent Developments/Updates
    Table 135. Gilead Sciences Corporation Information
    Table 136. Gilead Sciences Description and Business Overview
    Table 137. Gilead Sciences Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 138. Gilead Sciences Nanopharmaceuticals Product
    Table 139. Gilead Sciences Recent Developments/Updates
    Table 140. OSI Pharmaceuticals Corporation Information
    Table 141. OSI Pharmaceuticals Description and Business Overview
    Table 142. OSI Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 143. OSI Pharmaceuticals Nanopharmaceuticals Product
    Table 144. OSI Pharmaceuticals Recent Developments/Updates
    Table 145. Kadmon Pharmaceuticals Corporation Information
    Table 146. Kadmon Pharmaceuticals Description and Business Overview
    Table 147. Kadmon Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 148. Kadmon Pharmaceuticals Nanopharmaceuticals Product
    Table 149. Kadmon Pharmaceuticals Recent Developments/Updates
    Table 150. Samyang Biopharm Corporation Information
    Table 151. Samyang Biopharm Description and Business Overview
    Table 152. Samyang Biopharm Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 153. Samyang Biopharm Nanopharmaceuticals Product
    Table 154. Samyang Biopharm Recent Developments/Updates
    Table 155. Mitsubishi Pharma Corporation Information
    Table 156. Mitsubishi Pharma Description and Business Overview
    Table 157. Mitsubishi Pharma Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 158. Mitsubishi Pharma Nanopharmaceuticals Product
    Table 159. Mitsubishi Pharma Recent Developments/Updates
    Table 160. Kaken Pharmaceutical Corporation Information
    Table 161. Kaken Pharmaceutical Description and Business Overview
    Table 162. Kaken Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 163. Kaken Pharmaceutical Nanopharmaceuticals Product
    Table 164. Kaken Pharmaceutical Recent Developments/Updates
    Table 165. Selecta Biosciences Corporation Information
    Table 166. Selecta Biosciences Description and Business Overview
    Table 167. Selecta Biosciences Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 168. Selecta Biosciences Nanopharmaceuticals Product
    Table 169. Selecta Biosciences Recent Developments/Updates
    Table 170. Par Pharmaceutical Corporation Information
    Table 171. Par Pharmaceutical Description and Business Overview
    Table 172. Par Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 173. Par Pharmaceutical Nanopharmaceuticals Product
    Table 174. Par Pharmaceutical Recent Developments/Updates
    Table 175. Cerulean Pharma Corporation Information
    Table 176. Cerulean Pharma Description and Business Overview
    Table 177. Cerulean Pharma Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 178. Cerulean Pharma Nanopharmaceuticals Product
    Table 179. Cerulean Pharma Recent Developments/Updates
    Table 180. Navidea Biopharmaceuticals Corporation Information
    Table 181. Navidea Biopharmaceuticals Description and Business Overview
    Table 182. Navidea Biopharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 183. Navidea Biopharmaceuticals Nanopharmaceuticals Product
    Table 184. Navidea Biopharmaceuticals Recent Developments/Updates
    Table 185. Lummy Corporation Information
    Table 186. Lummy Description and Business Overview
    Table 187. Lummy Nanopharmaceuticals Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 188. Lummy Nanopharmaceuticals Product
    Table 189. Lummy Recent Developments/Updates
    Table 190. Key Raw Materials Lists
    Table 191. Raw Materials Key Suppliers Lists
    Table 192. Nanopharmaceuticals Distributors List
    Table 193. Nanopharmaceuticals Customers List
    Table 194. Nanopharmaceuticals Market Trends
    Table 195. Nanopharmaceuticals Market Drivers
    Table 196. Nanopharmaceuticals Market Challenges
    Table 197. Nanopharmaceuticals Market Restraints
    Table 198. Research Programs/Design for This Report
    Table 199. Key Data Information from Secondary Sources
    Table 200. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Nanopharmaceuticals
    Figure 2. Global Nanopharmaceuticals Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Nanopharmaceuticals Market Share by Type in 2023 & 2030
    Figure 4. Liposomes Product Picture
    Figure 5. Polymeric Micelles Product Picture
    Figure 6. Solid Lipid Nanoparticles Product Picture
    Figure 7. Microemulsion and Nnanoemulsion Product Picture
    Figure 8. Nanosuspension Product Picture
    Figure 9. Global Nanopharmaceuticals Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 10. Global Nanopharmaceuticals Market Share by Application in 2023 & 2030
    Figure 11. Cancer and Tumor
    Figure 12. Autoimmune Disorders
    Figure 13. Inflammation
    Figure 14. Others
    Figure 15. Global Nanopharmaceuticals Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Nanopharmaceuticals Market Size (2019-2030) & (US$ Million)
    Figure 17. Global Nanopharmaceuticals Sales (2019-2030) & (K MT)
    Figure 18. Global Nanopharmaceuticals Average Price (USD/MT) & (2019-2030)
    Figure 19. Nanopharmaceuticals Report Years Considered
    Figure 20. Nanopharmaceuticals Sales Share by Manufacturers in 2023
    Figure 21. Global Nanopharmaceuticals Revenue Share by Manufacturers in 2023
    Figure 22. The Global 5 and 10 Largest Nanopharmaceuticals Players: Market Share by Revenue in 2023
    Figure 23. Nanopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 24. Global Nanopharmaceuticals Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 25. North America Nanopharmaceuticals Sales Market Share by Country (2019-2030)
    Figure 26. North America Nanopharmaceuticals Revenue Market Share by Country (2019-2030)
    Figure 27. U.S. Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Canada Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Europe Nanopharmaceuticals Sales Market Share by Country (2019-2030)
    Figure 30. Europe Nanopharmaceuticals Revenue Market Share by Country (2019-2030)
    Figure 31. Germany Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. France Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. U.K. Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Italy Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Russia Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Asia Pacific Nanopharmaceuticals Sales Market Share by Region (2019-2030)
    Figure 37. Asia Pacific Nanopharmaceuticals Revenue Market Share by Region (2019-2030)
    Figure 38. China Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Japan Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. South Korea Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. India Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Australia Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Taiwan Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Indonesia Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Thailand Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Malaysia Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Philippines Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Latin America Nanopharmaceuticals Sales Market Share by Country (2019-2030)
    Figure 49. Latin America Nanopharmaceuticals Revenue Market Share by Country (2019-2030)
    Figure 50. Mexico Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Brazil Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Argentina Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Middle East & Africa Nanopharmaceuticals Sales Market Share by Country (2019-2030)
    Figure 54. Middle East & Africa Nanopharmaceuticals Revenue Market Share by Country (2019-2030)
    Figure 55. Turkey Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 57. U.A.E Nanopharmaceuticals Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 58. Global Sales Market Share of Nanopharmaceuticals by Type (2019-2030)
    Figure 59. Global Revenue Market Share of Nanopharmaceuticals by Type (2019-2030)
    Figure 60. Global Nanopharmaceuticals Price (USD/MT) by Type (2019-2030)
    Figure 61. Global Sales Market Share of Nanopharmaceuticals by Application (2019-2030)
    Figure 62. Global Revenue Market Share of Nanopharmaceuticals by Application (2019-2030)
    Figure 63. Global Nanopharmaceuticals Price (USD/MT) by Application (2019-2030)
    Figure 64. Nanopharmaceuticals Value Chain
    Figure 65. Nanopharmaceuticals Production Process
    Figure 66. Channels of Distribution (Direct Vs Distribution)
    Figure 67. Distributors Profiles
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS